SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-21-328887
Filing Date
2021-11-15
Accepted
2021-11-15 07:02:34
Documents
14
Period of Report
2021-11-15
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d257549d8k.htm   iXBRL 8-K 26136
2 EX-99.1 d257549dex991.htm EX-99.1 24618
6 GRAPHIC g257549g1113024722582.jpg GRAPHIC 5710
  Complete submission text file 0001193125-21-328887.txt   192813

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA logc-20211115.xsd EX-101.SCH 2892
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE logc-20211115_lab.xml EX-101.LAB 18888
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE logc-20211115_pre.xml EX-101.PRE 11860
7 EXTRACTED XBRL INSTANCE DOCUMENT d257549d8k_htm.xml XML 3477
Mailing Address 65 HAYDEN AVE 2ND FLOOR LEXINGTON MA 02421
Business Address 65 HAYDEN AVE 2ND FLOOR LEXINGTON MA 02421 617-245-0399
LogicBio Therapeutics, Inc. (Filer) CIK: 0001664106 (see all company filings)

IRS No.: 471514975 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38707 | Film No.: 211406248
SIC: 2836 Biological Products, (No Diagnostic Substances)